Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/3: 109-116 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/3: 109-116

Title: Insulin therapy in diabetic patients undergoing surgery in orthopedics and neurosurgery 

Authors: Płusa T, Baranowski P, Szymczak Z, Baranowska A.

More details

04-03-2019

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Insulin therapy in diabetic patients undergoing surgery in orthopedics and neurosurgery


Płusa T1, Baranowski P2, Szymczak Z2, Baranowska A2.

1Medical Faculty, Łazarski University, Warsaw, Poland;2Department of Neurorthopedics, Mazovian Center of Rehabilitation STOCER, Konstancin-Jeziorna, Poland

International Review of Medical Practice, 2019; Vol. 25, No. 3, 109

The number of diabetic patients undergoing surgery in orthopedics and neurosurgery is steadily increasing. Changes in the musculoskeletal system are in fact due to the micro- and macrocirculatory disorders that underlie diabetes. Proper glycemic control in the perioperative period, as well as the use of insulin during convalescence has been confirmed in many clinical analyzes. Insulin, in addition to controlling glucose, works together with growth factors (GF – growth factor, IGF – insulin-like growth factor) in an anabolic way, resulting in faster healing of the postoperative wound and acceleration of muscle and bone tissue cell proliferation. Insulin therapy in patients with diabetes significantly reduces the risk of infection of the surgical site and the number of infectious complications, which translates into shortening the duration of hospital treatment and reducing the cost of treatment. Maintenance of insulin treatment in patients after orthopedic and neurosurgical procedures finds its full pathogenetic justification.

Key words: diabetes, insulin therapy, surgical treatment, orthopedics, neurosurgery